Letko Brosseau & Associates Inc. Sells 12,300 Shares of CVS Health Corporation $CVS

Letko Brosseau & Associates Inc. cut its holdings in shares of CVS Health Corporation (NYSE:CVS) by 1.1% during the 3rd quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 1,082,965 shares of the pharmacy operator’s stock after selling 12,300 shares during the quarter. Letko Brosseau & Associates Inc. owned 0.08% of CVS Health worth $92,799,000 as of its most recent SEC filing.

Other hedge funds and other institutional investors also recently made changes to their positions in the company. Eurizon Capital SGR S.p.A. raised its stake in CVS Health by 256.6% in the third quarter. Eurizon Capital SGR S.p.A. now owns 322,035 shares of the pharmacy operator’s stock valued at $27,631,000 after purchasing an additional 231,740 shares in the last quarter. Werba Rubin Papier Wealth Management lifted its position in CVS Health by 10.9% during the third quarter. Werba Rubin Papier Wealth Management now owns 3,427 shares of the pharmacy operator’s stock worth $294,000 after purchasing an additional 337 shares during the period. Endeavor Private Wealth Inc. grew its stake in CVS Health by 13.9% during the third quarter. Endeavor Private Wealth Inc. now owns 3,642 shares of the pharmacy operator’s stock worth $312,000 after buying an additional 445 shares in the last quarter. Maryland State Retirement & Pension System grew its stake in CVS Health by 14.9% during the third quarter. Maryland State Retirement & Pension System now owns 78,768 shares of the pharmacy operator’s stock worth $6,750,000 after buying an additional 10,199 shares in the last quarter. Finally, Ritholtz Wealth Management increased its holdings in CVS Health by 7.6% in the 3rd quarter. Ritholtz Wealth Management now owns 27,787 shares of the pharmacy operator’s stock valued at $2,381,000 after buying an additional 1,967 shares during the period. 80.66% of the stock is currently owned by institutional investors and hedge funds.

Latest CVS Health News

These are some of the CVS news items that stood out recently:

• Positive Sentiment: CVS’s planned 2028 split could sharpen strategic focus and improve capital allocation, potentially unlocking value in its businesses. Wells Fargo kept an “overweight” rating and sees its $112 price target as implying upside, despite lowering the target from $123. Article: Can CVS Health’s 2028 Split Unlock Value Despite Execution Risks?
• Neutral Sentiment: Wells Fargo’s price-target cut signals more cautious valuation assumptions, though its continued overweight rating indicates the analyst remains positive on CVS. Article: Wells Fargo rating and price target
• Negative Sentiment: The split is not a guaranteed catalyst: coverage highlights separation costs and execution risks, while Aetna’s recovery and stronger pharmacy profits are weighed against PBM pressures and declining membership. Senator Elizabeth Warren has also criticized the plan, suggesting political scrutiny may continue. Article: Is CVS Stock Worth Buying as Aetna Recovers but PBM Risks Persist?

Wall Street Analysts Forecast Growth

Several brokerages have recently commented on CVS. Wells Fargo & Company dropped their target price on shares of CVS Health from $123.00 to $112.00 and set an “overweight” rating for the company in a research report on Thursday. Jefferies Financial Group reiterated a “buy” rating and set a $103.00 price target on shares of CVS Health in a research report on Wednesday, November 4th. UBS Group reduced their price target on shares of CVS Health from $118.00 to $107.00 and set a “buy” rating on the stock in a research report on Thursday, November 5th. Evercore reissued an “outperform” rating on shares of CVS Health in a research note on Wednesday, November 4th. Finally, Argus boosted their price objective on shares of CVS Health from $104.00 to $114.00 and gave the company a “buy” rating in a research report on Wednesday, August 19th. Twenty-three equities research analysts have rated the stock with a Buy rating and two have given a Hold rating to the company. According to data from MarketBeat, the stock presently has an average rating of “Moderate Buy” and a consensus price target of $107.79.

Insider Activity

In related news, EVP Prem Shah purchased 23,855 shares of the firm’s stock in a transaction that occurred on Friday, November 6th. The shares were bought at an average cost of $83.89 per share, with a total value of $2,001,195.95. Following the acquisition, the executive vice president owned 88,516 shares of the company’s stock, valued at $7,425,607.24. This trade represents a 36.89% increase in their position. The transaction was disclosed in a legal filing with the SEC, which is available through this hyperlink. Company insiders own 0.85% of the company’s stock.

CVS Health Stock Performance

NYSE:CVS opened at $89.69 on Friday. The stock’s 50-day simple moving average is $89.81 and its 200 day simple moving average is $89.00. The firm has a market capitalization of $114.76 billion, a PE ratio of 10.44, a price-to-earnings-growth ratio of 0.78 and a beta of 0.58. The company has a quick ratio of 0.66, a current ratio of 0.85 and a debt-to-equity ratio of 0.71. CVS Health Corporation has a twelve month low of $69.51 and a twelve month high of $110.68.

CVS Health (NYSE:CVS) last released its earnings results on Wednesday, November 4th. The pharmacy operator reported $2.09 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.65 by $0.44. The firm had revenue of $108.40 billion for the quarter, compared to analysts’ expectations of $104.72 billion. CVS Health had a return on equity of 13.65% and a net margin of 2.62%. The business’s revenue for the quarter was up 5.4% on a year-over-year basis. During the same quarter in the previous year, the business posted $1.60 earnings per share. On average, analysts anticipate that CVS Health Corporation will post 8.26 EPS for the current fiscal year.

CVS Health Announces Dividend

The business also recently declared a quarterly dividend, which was paid on Monday, November 2nd. Stockholders of record on Thursday, October 22nd were paid a $0.6650 dividend. This represents a $2.66 dividend on an annualized basis and a dividend yield of 3.0%. The ex-dividend date was Thursday, October 22nd. CVS Health’s dividend payout ratio (DPR) is presently 30.97%.

CVS Health Company Profile

CVS Health is a U.S.-based health care company that operates retail pharmacies, provides pharmacy benefit management services, and offers health insurance and other health services. Its businesses include CVS Pharmacy, pharmacy benefit manager CVS Caremark, and Aetna, its health benefits division. The company also provides care through MinuteClinic walk-in clinics and health care businesses including Oak Street Health and Signify Health. Its services span prescription fulfillment, pharmacy benefit management, health insurance, primary care, and in-home and community-based care.